EQ-5D and the EuroQol Group: Past, Present and Future
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Over the period 1987-1991 an inter-disciplinary five-country group developed the EuroQol instrument, a five-dimensional three-level generic measure subsequently termed the 'EQ-5D'. It was designed to measure and value health status. The salient features of its development and its consolidation and expansion are discussed. Initial expansion came, in particular, in the form of new language versions. Their development raised translation and semantic issues, experience with which helped feed into the design of two further instruments, the EQ-5D-5L and the youth version EQ-5D-Y. The expanded usage across clinical programmes, disease and condition areas, population surveys, patient-reported outcomes, and value sets is outlined. Valuation has been of continued relevance for the Group as this has allowed its instruments to be utilised as part of the economic appraisal of health programmes and their incorporation into health technology assessments. The future of the Group is considered in the context of: (1) its scientific strategy, (2) changes in the external environment affecting the demand for EQ-5D, and (3) a variety of issues it is facing in the context of the design of the instrument, its use in health technology assessment, and potential new uses for EQ-5D outside of clinical trials and technology appraisal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795
EuroQol: the current state of play
Brooks, R. (1996) · Health Policy · doi:10.1016/0168-8510(96)00822-6 · Cited by 5,815
Self-citationInterim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets
van Hout, B., Janssen, M. F., Feng, Y.-S., Kohlmann, T., Busschbach, J., Golicki, D., Lloyd, A., Scalone, L., Kind, P., & Pickard, A. S. (2012) · Value in Health · doi:10.1016/j.jval.2012.02.008 · Cited by 2,153
Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
Wille, N., Badia, X., Bonsel, G., Burström, K., Cavrini, G., Devlin, N., Egmar, A.-C., Greiner, W., Gusi, N., Herdman, M., et al. (2010) · Quality of Life Research · doi:10.1007/s11136-010-9648-y · Cited by 872 · cited 1×
“target, and how to value children’s health states [22, 23].”
BackgroundSelf-citationEconomic Evaluation in Health Care: Merging Theory with Practice
McGuire, A. J., & Drummond, M. (2002) · London School of Economics and Political Science Research Online (London School of Economics and Political Science) · Cited by 723
The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective
(2003) · Springer eBooks · doi:10.1007/978-94-017-0233-1 · Cited by 638
A social tariff for EuroQol: results from a UK general population surveyPreprint
Dolan, P., Gudex, C. M., Kind, P., & Williams, A. (1995) · RePEc: Research Papers in Economics · Cited by 611
Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study
Ravens-Sieberer, U., Wille, N., Badia, X., Bonsel, G., Burström, K., Cavrini, G., Devlin, N., Egmar, A.-C., Gusi, N., Herdman, M., et al. (2010) · Quality of Life Research · doi:10.1007/s11136-010-9649-x · Cited by 464 · cited 1×
“target, and how to value children’s health states [22, 23].”
BackgroundSelf-citationA Program of Methodological Research to Arrive at the New International EQ-5D-5L Valuation Protocol
Oppe, M., Devlin, N. J., van Hout, B., Krabbe, P. F. M., & de Charro, F. (2014) · Value in Health · doi:10.1016/j.jval.2014.04.002 · Cited by 428
Self-citationLongworth, L., Yang, Y., Young, T., Mulhern, B., Hernández Alava, M., Mukuria, C., Rowen, D., Tosh, J., Tsuchiya, A., Evans, P., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18090 · Cited by 417 · cited 2×
“However, this approach raises nontrivial issues, especially in connection with the consequences for health state valuations in the expanded instruments [33, 36].”
Background(2007) · EuroQol Group Monographs · doi:10.1007/1-4020-5511-0 · Cited by 367
Self-citationAssessing the performance of the EQ-VAS in the NHS PROMs programme
Feng, Y., Parkin, D., & Devlin, N. J. (2014) · Quality of Life Research · doi:10.1007/s11136-013-0537-z · Cited by 319 · cited 1×
“actually as a warm-up task for the VAS valuation tasks, and only later was its potential usefulness as a self-reported global measure of overall health recognised [5].”
BackgroundSelf-citationComparing the Standard EQ-5D Three-Level System with a Five-Level Version
Janssen, M. F., Birnie, E., Haagsma, J. A., & Bonsel, G. J. (2008) · Value in Health · doi:10.1111/j.1524-4733.2007.00230.x · Cited by 275
Rabin, R., Gudex, C., Selai, C., & Herdman, M. (2014) · Value in Health · doi:10.1016/j.jval.2013.10.006 · Cited by 269 · cited 2×
“These are produced following the EuroQol Group’s translation methodology, which also includes in-depth semantic testing of all wording in the target language, with a particular focus on the severity labels (see [11]).”
BackgroundMethodPsychometric Comparison of the Standard EQ-5D to a 5 Level Version in Cancer Patients
Pickard, A. S., De Leon, M. C., Kohlmann, T., Cella, D., & Rosenbloom, S. (2007) · Medical Care · doi:10.1097/01.mlr.0000254515.63841.81 · Cited by 259
Discrete Choice Modeling for the Quantification of Health States: The Case of the EQ-5D
Stolk, E. A., Oppe, M., Scalone, L., & Krabbe, P. F. M. (2010) · Value in Health · doi:10.1111/j.1524-4733.2010.00783.x · Cited by 145 · cited 1×
“investigated in 2008 using the three-level version [26].”
MethodSwinburn, P., Lloyd, A. J., Boye, K. S., Edson‐Heredia, E., Bowman, L., & Janssen, B. (2013) · Value in Health · doi:10.1016/j.jval.2013.10.003 · Cited by 112
An Exploratory Study to Test the Impact on Three “Bolt-On” Items to the EQ-5D
Yang, Y., Rowen, D., Brazier, J., Tsuchiya, A., Young, T., & Longworth, L. (2015) · Value in Health · doi:10.1016/j.jval.2014.09.004 · Cited by 108
Improving Cross-Sector Comparisons: Going Beyond the Health-Related QALY
Brazier, J. E., & Tsuchiya, A. (2015) · Applied Health Economics and Health Policy · doi:10.1007/s40258-015-0194-1 · Cited by 100
Operationalizing Value-Based Pricing of Medicines
Sussex, J., Towse, A., & Devlin, N. J. (2012) · PharmacoEconomics · doi:10.1007/s40273-012-0001-x · Cited by 98 · cited 1×
“inequalities) alongside the QALY (for example, the proposal to establish ‘value based pricing’ in the UK [45]), rather than a rejection of the QALY per se.”
BackgroundSelf-citationJanssen, M. F., Birnie, E., & Bonsel, G. J. (2008) · Quality of Life Research · doi:10.1007/s11136-008-9318-5 · Cited by 84
The Role of Patient Preferences in Cost-Effectiveness Analysis: A Conflict of Values?
Brazier, J. E., Dixon, S., & Ratcliffe, J. (2009) · PharmacoEconomics · doi:10.2165/11314840-000000000-00000 · Cited by 76 · cited 1×
“In contrast, judgements about what constitutes ‘good quality health care’, or individual patients’ choices between different treatments, might suggest a role for patient preferences, rather than those of the general public, in summarising and analysing EQ-5D data [43].”
BackgroundEffect of Adding a Sleep Dimension to the EQ-5D Descriptive System: A “Bolt-On” Experiment
Yang, Y., Brazier, J., & Tsuchiya, A. (2014) · Medical Decision Making · doi:10.1177/0272989x13480428 · Cited by 68 · cited 1×
“However, this approach raises nontrivial issues, especially in connection with the consequences for health state valuations in the expanded instruments [33, 36].”
BackgroundPickard, A. S., Kohlmann, T., Janssen, M. F., Bonsel, G., Rosenbloom, S., & Cella, D. (2007) · Medical Care · doi:10.1097/mlr.0b013e31805371aa · Cited by 66
QALYs as a measure of value in cancer
Devlin, N. J., & Lorgelly, P. K. (2016) · Journal of Cancer Policy · doi:10.1016/j.jcpo.2016.09.005 · Cited by 54
Self-citationPutting patient-reported outcomes on the ‘Big Data Road Map’.
Calvert, M., Thwaites, R., Kyte, D., & Devlin, N. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076815579896 · Cited by 52 · cited 1×
“EQ-5D has thus become part of the ‘big data’ revolution in health care [32].”
BackgroundSelf-citationThe EuroQol Group after 25 years
Brooks, R. G. (2012) · Springer eBooks · doi:10.1007/978-94-007-5158-3 · Cited by 46
Self-citationThe Future of Health Technology Assessment in Healthcare Decision Making in Asia
Yang, B. (2009) · PharmacoEconomics · doi:10.2165/11310280-000000000-00000 · Cited by 40
The descriptive system of the EuroQol Instrument
Gudex, C. M. (2006) · Springer eBooks · doi:10.1007/1-4020-3712-0_2 · Cited by 37 · cited 1×
“General agreement settled on the following: mobility, daily activities and self-care, psychological functioning, social and role performance, and pain or other health problems [4].”
BackgroundChoice of Outcome Measure in an Economic Evaluation: A Potential Role for the Capability Approach
Lorgelly, P. K. (2015) · PharmacoEconomics · doi:10.1007/s40273-015-0275-x · Cited by 33
Operationalising Value Based Pricing of Medicines: A Taxonomy of ApproachesPreprint
Sussex, J., Towse, A., & Devlin, N. J. (2015) · SSRN Electronic Journal · doi:10.2139/ssrn.2634410 · Cited by 21
Self-citationThe 1990 GP contract — meeting needs?
Silcock, J., & Ratcliffe, J. (1996) · Health Policy · doi:10.1016/0168-8510(95)00810-1 · Cited by 13
What concepts does the EQ-5D measure? Intentions and interpretations
Fox-Rushby, J. A., & Selai, C. E. (2003) · Springer eBooks · doi:10.1007/978-94-017-0233-1_10 · Cited by 11 · cited 1×
“A definition of EQ-5D concepts was provided and a series of recommendations for further research was made [9].”
BackgroundPriority setting for health in emerging markets
Glassman, A. L., Giedión, Ú., & McQueston, K. (2013) · Journal of Comparative Effectiveness Research · doi:10.2217/cer.13.12 · Cited by 11
The number of levels in the descriptive system
van Agt, H. M. E., & Bonsel, G. J. (2005) · Springer eBooks · doi:10.1007/1-4020-3712-0_3 · Cited by 10 · cited 1×
“1994 [12] regarding the three-level structure of the response options (no, some, extreme problems/unable to) and whether this was associated with ceiling effects and a lack of sensitivity to changes in health.”
BackgroundExploring the results of translating the EQ-5D into 11 European languages
Rabin, R., Herdman, M., Fox-Rushby, J. A., & Badia, X. C. (2003) · Springer eBooks · doi:10.1007/978-94-017-0233-1_12 · Cited by 10 · cited 1×
“A detailed account of translating EQ-5D into 11 European languages provided an insight into the translation process, and the challenges involved [10].”
BackgroundCost-Effectiveness Analysis: A View into the Abyss
Kind, P. (2014) · Applied Health Economics and Health Policy · doi:10.1007/s40258-014-0134-5 · Cited by 5 · cited 17×
“Furthermore, while formal, QALY-based HTA processes were initially restricted to Europe, Canada, Australia and New Zealand, similar HTA processes are now being established, or actively planned, in Asian, African, Middle Eastern and South American healthcare systems [46–48].”
BackgroundInfluentialEvolution & Influence of HTA in Emerging Markets
Yong, C., Jiang, Y., Sun, D., & Duttagupta, S. (2015) · Value in Health · doi:10.1016/j.jval.2015.09.1805 · Cited by 3
Research works printed but not linked: 6
- Nice Guide to the methods of technology appraisal 2004 London National Institute for Clinical Excellence 27905712
- Herdman M, Kind P, Chevalier J, Gudex C, de Pourvourville G. Investigation of labels for additional EQ-5D levels: results of the main study + 1. In: Busschbach J, Rabin R, de Charro F, editors. 24th Scientific Plenary Meeting of the EuroQol Group Proceedings. The Hague: EuroQol Group; 2007. p. 99–151.
- Lloyd A, Quadri N. Testing alternative labels for a UK English five level version of EQ-5D. In: Scalone L, Mantovani LG, editors. 25th Scientific Plenary Meeting of the EuroQol Group Proceedings. Baveno: EuroQol Group; 2008. p. 41–73.
- Appleby J Devlin N Parkin D Using patient reported outcomes to improve health care 2015 Chichester Wiley
- Bansback N Trenaman L Bryan S Johnson J 2015 using routine patient reported outcome measures to enhance patient decision making: a proof of concept study Qual Life Res 2015 24 109
- Sussex J Towse A Devlin N Operationalizing value-based pricing of medicines Pharmacoeconomics. 2013 31 1 10 10.1007/s40273-012-0001-x 23329588 · DOI
Cited by
Valuing health-related quality of life: an EQ-5D-5L value set for England
Devlin, N. J., Shah, K. K., Feng, Y., Mulhern, B., & van Hout, B. (2018) · Health Economics · doi:10.1002/hec.3564 · Cited by 1,356
Self-citationPsychometric properties of the EQ-5D-5L: a systematic review of the literature
Feng, Y.-S., Kohlmann, T., Janssen, M. F., & Buchholz, I. (2021) · Quality of Life Research · doi:10.1007/s11136-020-02688-y · Cited by 917
Ferguson, R. J., Palmer, A. J., Taylor, A., Porter, M. L., Malchau, H., & Glyn-Jones, S. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31777-x · Cited by 634
Comorbid depression in medical diseases
Gold, S. M., Köhler-Forsberg, O., Moss-Morris, R., Mehnert, A., Miranda, J. J., Bullinger, M., Steptoe, A., Whooley, M. A., & Otte, C. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0200-2 · Cited by 534
United States Valuation of EQ-5D-5L Health States Using an International Protocol
Pickard, A. S., Law, E. H., Jiang, R., Pullenayegum, E., Shaw, J. W., Xie, F., Oppe, M., Boye, K. S., Chapman, R. H., Gong, C. L., et al. (2019) · Value in Health · doi:10.1016/j.jval.2019.02.009 · Cited by 389
Metadata
- Authors
- Devlin, N. J., & Brooks, R.
- Affiliations
- Office Of Health Economics (GB)
- EuroQol Research Foundation (NL)
- Corresponding author
- Devlin, Nancy J.
- ORCID
- Devlin, Nancy J.
- Venue
- Applied Health Economics and Health Policy
- Published
- 2017-02-13
- Volume
- 15
- Issue
- 2
- Pages
- 127-137
- ISSN
- 1175-5652 (ISSN-L)
- 1179-1896
- PMC
- PMC5343080
- OpenAlex
- W2587851012
- Cited by
- 1,189
- References
- 39
- Citations by year
- 2026: 126 · 2025: 163 · 2024: 166 · 2023: 161 · 2022: 173 · 2021: 151 · 2020: 129 · 2019: 52 · 2018: 53 · 2017: 11
- FWCI
- 23.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Applied Health Economics and Health Policy (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- EuroQol Research Foundation
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Environmental Valuation
- Social Sciences › Sociology and Political Science › Delphi Technique in Research
- Keywords
- EQ-5D, health status measurement, health-related quality of life, EQ-5D-5L, EQ-5D-Y, language versions, health technology assessment, value sets, patient-reported outcomes
- MeSH terms
- Diet, Healthy, Delivery of Health Care, Europe, Forecasting, Humans, Quality Assurance, Health Care, Quality Indicators, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.